Literature DB >> 23771528

Suppression of hypothalamic-pituitary-adrenal axis by acute heroin challenge in rats during acute and chronic withdrawal from chronic heroin administration.

Yan Zhou1, Francesco Leri, Ann Ho, Mary Jeanne Kreek.   

Abstract

It is known that heroin dependence and withdrawal are associated with changes in the hypothalamic-pituitary-adrenal (HPA) axis. The objective of these studies in rats was to systematically investigate the level of HPA activity and response to a heroin challenge at two time points during heroin withdrawal, and to characterize the expression of associated stress-related genes 30 min after each heroin challenge. Rats received chronic (10-day) intermittent escalating-dose heroin administration (3 × 2.5 mg/kg/day on day 1; 3 × 20 mg/kg/day by day 10). Hormonal and neurochemical assessments were performed in acute (12 h after last heroin injection) and chronic (10 days after the last injection) withdrawal. Both plasma ACTH and corticosterone levels were elevated during acute withdrawal, and heroin challenge at 20 mg/kg (the last dose of chronic escalation) at this time point attenuated this HPA hyperactivity. During chronic withdrawal, HPA hormonal levels returned to baseline, but heroin challenge at 5 mg/kg decreased ACTH levels. In contrast, this dose of heroin challenge stimulated the HPA axis in heroin naïve rats. In the anterior pituitary, pro-opiomelanocortin (POMC) mRNA levels were increased during acute withdrawal and retuned to control levels after chronic withdrawal. In the medial hypothalamus, however, the POMC mRNA levels were decreased during acute withdrawal, and increased after chronic withdrawal. Our results suggest a long-lasting change in HPA abnormal responsivity during chronic heroin withdrawal.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23771528      PMCID: PMC3735680          DOI: 10.1007/s11064-013-1091-3

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  42 in total

1.  Involvement of the lateral hypothalamic peptide orexin in morphine dependence and withdrawal.

Authors:  Dan Georgescu; Venetia Zachariou; Michel Barrot; Michihiro Mieda; Jon T Willie; Amelia J Eisch; Masashi Yanagisawa; Eric J Nestler; Ralph J DiLeone
Journal:  J Neurosci       Date:  2003-04-15       Impact factor: 6.167

2.  Medical safety and side effects of methadone in tolerant individuals.

Authors:  M J Kreek
Journal:  JAMA       Date:  1973-02-05       Impact factor: 56.272

3.  Cortisol levels during chronic naltrexone maintenance treatment in ex-opiate addicts.

Authors:  T R Kosten; M J Kreek; J Ragunath; H D Kleber
Journal:  Biol Psychiatry       Date:  1986-02       Impact factor: 13.382

4.  Measuring the incentive value of escalating doses of heroin in heroin-dependent Fischer rats during acute spontaneous withdrawal.

Authors:  Katharine M Seip; Brian Reed; Ann Ho; Mary Jeanne Kreek
Journal:  Psychopharmacology (Berl)       Date:  2011-07-07       Impact factor: 4.530

5.  Opioid inhibition of immunoreactive corticotropin-releasing factor secretion into the hypophysial-portal circulation of rats.

Authors:  P M Plotsky
Journal:  Regul Pept       Date:  1986-12-30

6.  Hypothalamic-pituitary-adrenal activity and pro-opiomelanocortin mRNA levels in the hypothalamus and pituitary of the rat are differentially modulated by acute intermittent morphine with or without water restriction stress.

Authors:  Y Zhou; R Spangler; C E Maggos; X M Wang; J S Han; A Ho; M J Kreek
Journal:  J Endocrinol       Date:  1999-11       Impact factor: 4.286

7.  Quantitative analysis of corticotropin-releasing factor and arginine vasopressin mRNA in the hypothalamus during chronic morphine treatment in rats: an in situ hybridization study.

Authors:  M L Laorden; M V Milanés; E Angel; P Tankosic; A Burlet
Journal:  J Neuroendocrinol       Date:  2003-06       Impact factor: 3.627

8.  Altered HPA axis responsivity to metyrapone testing in methadone maintained former heroin addicts with ongoing cocaine addiction.

Authors:  J H Schluger; L Borg; A Ho; M J Kreek
Journal:  Neuropsychopharmacology       Date:  2001-05       Impact factor: 7.853

9.  Secretion of corticotrophin and its hypothalamic releasing factor in response to morphine and opioid peptides.

Authors:  J C Buckingham
Journal:  Neuroendocrinology       Date:  1982       Impact factor: 4.914

10.  Intermittent morphine administration induces dependence and is a chronic stressor in rats.

Authors:  Hani Houshyar; Francisca Gomez; Sotara Manalo; Aditi Bhargava; Mary F Dallman
Journal:  Neuropsychopharmacology       Date:  2003-11       Impact factor: 7.853

View more
  8 in total

Review 1.  Substance use modulates stress reactivity: Behavioral and physiological outcomes.

Authors:  Anne Q Fosnocht; Lisa A Briand
Journal:  Physiol Behav       Date:  2016-02-19

2.  Individual differences in gene expression of vasopressin, D2 receptor, POMC and orexin: vulnerability to relapse to heroin-seeking in rats.

Authors:  Yan Zhou; Francesco Leri; Erin Cummins; Mary Jeanne Kreek
Journal:  Physiol Behav       Date:  2014-11-09

3.  Heroin addiction engages negative emotional learning brain circuits in rats.

Authors:  Stephanie A Carmack; Robin J Keeley; Janaina C M Vendruscolo; Emily G Lowery-Gionta; Hanbing Lu; George F Koob; Elliot A Stein; Leandro F Vendruscolo
Journal:  J Clin Invest       Date:  2019-03-26       Impact factor: 14.808

4.  Dorsal hippocampal interleukin-1 signaling mediates heroin withdrawal-enhanced fear learning.

Authors:  Shveta V Parekh; Jacqueline E Paniccia; Christina L Lebonville; Donald T Lysle
Journal:  Psychopharmacology (Berl)       Date:  2020-08-28       Impact factor: 4.530

5.  The gut microbiota mediates reward and sensory responses associated with regimen-selective morphine dependence.

Authors:  Kevin Lee; Helen E Vuong; David J Nusbaum; Elaine Y Hsiao; Christopher J Evans; Anna M W Taylor
Journal:  Neuropsychopharmacology       Date:  2018-09-10       Impact factor: 7.853

6.  Hippocampal TNF-α Signaling Mediates Heroin Withdrawal-Enhanced Fear Learning and Withdrawal-Induced Weight Loss.

Authors:  Shveta V Parekh; Jacqueline E Paniccia; Lydia O Adams; Donald T Lysle
Journal:  Mol Neurobiol       Date:  2021-02-13       Impact factor: 5.590

Review 7.  Targeting opioid receptor signaling in depression: do we need selective κ opioid receptor antagonists?

Authors:  Sarah J Bailey; Stephen M Husbands
Journal:  Neuronal Signal       Date:  2018-05-14

8.  Naloxone precipitated withdrawal increases dopamine release in the dorsal striatum of opioid dependent men.

Authors:  Ehsan Shokri-Kojori; Gene-Jack Wang; Nora D Volkow
Journal:  Transl Psychiatry       Date:  2021-09-01       Impact factor: 6.222

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.